- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/08 - Oxidoreductases (1.), e.g. luciferase acting on hydrogen peroxide as acceptor (1.11)
Patent holdings for IPC class C12N 9/08
Total number of patents in this class: 453
10-year publication summary
|
37
|
35
|
25
|
35
|
24
|
28
|
35
|
50
|
56
|
26
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novozymes A/S | 3321 |
30 |
| Massachusetts Institute of Technology | 10062 |
8 |
| Codexis, Inc. | 798 |
8 |
| Consejo Superior de Investigaciones Cientificas (csic) | 1371 |
8 |
| Cornell University | 3307 |
8 |
| BASF SE | 20940 |
7 |
| Rockwool A/S | 784 |
7 |
| Lpoxy Therapeutics, Inc | 23 |
6 |
| Braskem S.A. | 471 |
5 |
| Solugen, Inc. | 125 |
5 |
| Chr. Hansen A/S | 1058 |
5 |
| Agilent Technologies, Inc. | 2638 |
4 |
| Novozymes, Inc. | 287 |
4 |
| Northwestern University | 3398 |
4 |
| The Brigham and Women's Hospital, Inc. | 2195 |
4 |
| Meiji Seika Pharma Co., Ltd. | 247 |
4 |
| University of Massachusetts | 2225 |
4 |
| Gecco Biotech B.V. | 4 |
4 |
| Abbott Diabetes Care Inc. | 2030 |
3 |
| Centre National de La Recherche Scientifique | 10464 |
3 |
| Other owners | 322 |